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Background/Aims: The UK National Screening Committee (NSC) has set 18 standards for 
diabetic retinopathy (DR) screening services in England and Wales, the ﬁ  rst of which is to 
reduce new visual impairment (VI) due to DR by 10% within 5 years. This study examined the 
incidence of VI due to DR in Cambridgeshire (City, South, and Huntingdonshire) in order to 
establish a baseline rate of VI registration.
Methods: A retrospective review of all certiﬁ  cates of visual impairment (CVI) for 2004 and 
2005 was conducted. Hospital records of patients registered due to DR were reviewed to ascertain 
conformity to NSC Standards. The incidence of VI registration due to DR was calculated.
Results: The number of registrations predominantly due to DR was 18; 13 visually impaired 
and 5 with severe VI. The rates of VI and severe VI predominantly due to DR were 17.1 and 
6.5 per million per year, respectively. The VI and severe VI registration rates in the diabetic 
population were 600 and 230 per million per year, respectively.
Conclusion: The severe VI registration rate due to DR lies within the national standard. The 
VI registration rate exceeds 1990–1991 national standards but lies within 1999–2000 national 
ﬁ  gures.
Keywords: diabetic retinopathy, visual impairment, severe visual impairment, registration, 
certiﬁ  cation of visual impairment
Introduction
The World Health Organization has made prevention of visual impairment (VI) an 
international priority. In order to prevent VI, data on incidence and causes of VI need 
to be obtained. From this data, priorities for prevention, treatment, and management 
can be identiﬁ  ed, and strategies and resources allocated appropriately. For many 
years, diabetes has been a leading cause of VI in many countries, and still takes a 
major toll on VI.
In England and Wales, the UK National Screening Committee for Diabetic 
Retinopathy has set 18 service objectives and quality assurance standards for 
diabetic retinopathy screening services.1,2 The ﬁ  rst service objective is to reduce new 
blindness due to diabetic retinopathy (DR).2 It stipulates that local services will need 
to prospectively audit both certiﬁ  cations of visual impairment (CVI) and incidence 
of VI predominantly due to DR in order to establish a baseline. The standard accept-
able annual registration rate for severe VI and VI due to DR is 9.5 and 9.3 per million 
per year for England and Wales, respectively. These ﬁ  gures have been derived from 
national data in 1990–1991.3 The minimum standard achievable is a 10% reduction in 
severe VI and VI registration rate within 5 years of the start of the screening program. 
The desirable standard is 40% reduction.
From 2006 and annually thereafter, DR screening programmes in England and 
Wales will be required to submit an annual report to the National Screening Programme, 
containing general information about the service offered and information to support Clinical Ophthalmology 2009:3 76
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an assessment against the Service Objectives and Quality 
Assurance Standards for the programme. All programmes 
in England and Wales will be required to use a report 
template in order to facilitate the collation and comparison 
of data.4 Locally derived data on new VI should be included 
in the annual report submitted to the National Screening 
Programme.
Prior to 2005, screening for DR in Cambridgeshire was 
largely hospital-based, with patients being referred by their 
general practitioners, diabetic physicians, or optometrists 
directly to ophthalmologists at either Addenbrookes or 
Hinchingbrooke Hospital. Optometrists have recently been 
trained to perform optometric based screening, and to refer 
patients in a timely manner with maculopathy (M1), preprolif-
erative retinopathy (R2), and proliferative retinopathy (R3).
In November 2003, the CVI replaced the BD8 form in 
England. The new forms allowed space to record the patient’s 
visual function. Table 1 shows the deﬁ  nitions of severe VI and 
VI. These apply to the function of the better eye; people with 
good vision in one eye are not eligible for certiﬁ  cation.
This is the first study to obtain the severe VI and 
VI registration rates predominantly due to DR in south 
Cambridgeshire, Cambridge city, and Huntingdonshire. It 
was performed to establish a reference point of VI registration 
due to DR at the beginning of the screening program.
Methods
A retrospective review of all CVI for patients with 
Cambridgeshire post codes over 24 months from January 1, 
2004 to December 31, 2005 was conducted. The type of 
VI, cause of VI and patient’s age were noted for each form. 
An attempt was made to validate the certiﬁ  cates of VI 
with the central list of all new registrations of VI held by 
Cambridgeshire Social Services.
Population data was obtained from Census 2001 and 
Cambridgeshire primary care trusts to determine the total and 
diabetic populations of South Cambridgeshire, Cambridge 
city and Huntingdon. We had to exclude East Cambridgeshire 
and the Fenlands as patients from these areas attend other 
local district general hospitals eg, Queen Elizabeth Hospital 
King’s Lynn for VI assessment and registration. The annual 
registration rates of severe VI and VI due to DR were 
calculated per million population per year. In addition, the 
rate per million diabetic patients and prevalence of diabetes 
were calculated.
Results
From January 1, 2004 to December 31, 2005, there 
were 367 CVI for patients from Cambridgeshire, Cambridge 
city, and Huntingdonshire. Two forms were incomplete (the 
type of VI was not stated). Of the 365 completed forms there 
were 156 severe VI and 209 VI registrations. Some patients 
had more than one cause of VI. Each cause was noted which 
resulted in the number of causes (384) exceeding the number 
of registration forms (365). The leading causes of VI registra-
tion were age-related macular degeneration in 224 or 61.4% 
of patients, glaucoma (43 or 11.8%), and optic neuropathy 
(27 or 7.4%), (Table 2).
According to Census 2001, the total population of South 
Cambridgeshire, Cambridge City and Huntingdonshire is 
395,933. The number of registrations predominantly due to 
DR was 18; 13 visually impaired and 5 with severe VI. The 
rates of severe VI and VI registration predominantly due to 
DR were 17.1 and 6.5 per million per year, respectively. The 
diabetic population of South Cambridgeshire (2729), Cam-
bridge City (3361) and Huntingdonshire (4752) in June 2005 
was 10,842, and the prevalence of diabetes in this population 
of Cambridgeshire is calculated to be 2.74%. The severe VI 
and VI registration rates in the diabetic population were 230 
and 600 per million population with diagnosed diabetes per 
year, respectively. These results are summarized in Table 3.
Discussion
In our study, DR was the ﬁ  fth leading cause of registered VI, 
superseded by age-related macular degeneration, glaucoma, 
optic neuropathy, and visual cortex disorder in that order. 
Table 1 Deﬁ  nitions of severe visual impairment and visual impairment used in the UK (apply to the better eye)
Severe visual impairment Visual impairment
Worse than 3/60 (corrected visual acuity) 3/60 or 6/60 with full visual ﬁ  eld
or or
Worse than 6/60 with very contracted visual ﬁ  elds 6/24 or worse with moderate constriction of visual ﬁ  eld
or or
6/60 or above with a very contracted visual ﬁ  eld especially 
in the lower part of the ﬁ  eld
6/18 or better with gross visual ﬁ  eld defectsClinical Ophthalmology 2009:3 77
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In persons of working age (16–64 years), the leading cause 
of VI registration was optic neuropathy followed by retinitis 
pigmentosa (Table 2). The speciﬁ  c causes of optic neuropathy 
were not stated in most instances on the CVI form. Most optic 
neuropathies were congenital or secondary to demyelination 
and did not include diabetic or glaucomatous optic neuropa-
thy. Further studies are needed to clarify the types of optic 
neuropathy, by examining the patient records. A comparison 
of the demographic proﬁ  le of our study population with that 
of England and Wales reveals a younger age proﬁ  le (Table 4). 
There are 0.8% less persons aged 75 years and over, and 
0.6% more persons in the 0–15 year age group of Cambridge 
city, South Cambridgeshire, and Huntingdonshire. These 
differences in age proﬁ  le may contribute to the differences 
observed.
Three diabetic patients were of working age (16–64 years). 
From our study, DR does not appear to be the leading cause of 
CVI in the working age group in this population. This ﬁ  nding 
is contrary to that of Bunce and colleagues5 who found that 
DR was the leading cause of VI in the working age group in 
England and Wales in 1999–2000.
The severe VI registration rate of 6.5 per million per year 
meets the national standard of 9.5 per million per year. The 
VI registration rate was 17.1 per million per year, and almost 
doubles the current national standard of 9.3 per million per 
year. However, new data on national VI registration has 
emerged from a study carried out by Bunce and colleagues5 
in 1999–2000. In this study the rate of certiﬁ  cation of VI 
due to DR was 38.4 per million per year, compared to 
19.9 per million per year in 1990–1991.3,6 These rates have 
doubled over the nine years, partly explained by increased 
VI registration rates during the time interval 1991–1999, an 
aging population, and increasing prevalence of Type 2 and 
Type 1 diabetes.5 Given these new ﬁ  gures, we recommend 
that the national standards of severe VI and VI registration 
rates be revised. A severe VI registration rate of 12 per 
million population per year has been reported for Fife from 
1990–1999,7 and a severe VI registration rate of 10 per million 
Table 2 Causes of certiﬁ  cation of visual impairment (VI) in Cambridgeshire (City, South, and Hunts), 2004–2005
Cause of visual 
Impairment (VI)
Number of 
occurrences
Percentage of 
patients n = 365
VI Severe VI 0–15 years 15–64 years 65 + years
ARMD 224 61.4% 125 99 0 2 222
Glaucoma 43 11.8% 27 16 0 2 41
Retinitis pigmentosa 12 3.3% 5 7 0 7 5
Diabetic retinopathy 18 4.9% 13 5 0 3 15
Visual cortex disorder 19 5.2% 15 4 1 5 13
Optic neuropathy 27 7.4% 18 9 3 12 12
Retinal detachment 7 2% 5 2 0 2 5
Cause unstated 12 3.3% 6 6 4 1 7
Others 22 6.0% 14 8 1 7 14
Total occurrences 384 228 156 9 41 334
Total CVI forms 365 209 156 9 41 315
Table 3 Summary of registrations of visual impairment (VI) due to diabetic retinopathy (DR) in Cambridgeshire (City, South, and Hunts) 
(2004–2005)
Number of registrations with severe VI due to DR 5 (3.2% of severe VI registrations)
Number of registrations with partial VI due to DR 13 (6.2% of partial VI registrations)
Number of registrations with VI due to DR in working
age group (16–64 years)
0% of severe VI registrations
1.4% of partial VI registrations
Severe VI registration rate due to DR 6.5 per million population per year
Partial VI registration rate due to DR 17.1 per million population per year
Number of diabetics in Cambs City, South, Hunts 2005 10,842
Prevalence of diabetes 2.74%
Severe VI registration rate in diabetics 230 per million diabetics per year
Partial VI registration rate in diabetics 600 per million diabetics per yearClinical Ophthalmology 2009:3 78
Gordon-Bennett et al
per year and a VI registration rate of 24 per million per year 
was reported for Leeds for 2002.8
The prevalence of diabetes in South Cambridgeshire, 
Cambridge city, and Huntingdonshire (2.74%) is less than the 
national prevalence estimated as 4.26%.9 The prevalence in 
Leeds is 2.9%.8 The region of Cambridgeshire studied has about 
5% more Whites than the ethnic proﬁ  le of England/Wales, 
(Table 4). Likewise, our studied region has 2.8% less Asians 
and 2.3% less Blacks than England/Wales. This difference 
might account for the slightly lower prevalence of diabetes 
than the national prevalence, as there is well documented 
evidence of an increased prevalence of diabetes in Asians and 
Blacks.10,11 The severe VI and VI registration rates per million 
diabetic patients per year were 230 and 600 respectively. 
These rates are lower than the corresponding rates in the 
diabetic population of Leeds of 337 and 817, respectively.8 
The rates of registration in our study are also lower than the 
severe VI registration rate of 640 per million diabetics per 
year reported for Fife between 1990–1999,7 and similar to 
the VI registration rate of 530 per million diabetics per year 
calculated for Tayside in 1998.12 This interregional variation 
may be related to differing population proﬁ  les.13,14
Addenbrookes Hospital is a tertiary referral hospital in 
Cambridge city and Hinchingbrooke Hospital is a secondary 
care centre which serves as a district general hospital for 
Huntingdonshire and other surrounding subpopulations of 
Cambridgeshire. We questioned whether our relatively low 
rates of registration of VI due to diabetes were due to the nature 
of these hospitals. Geographically, Addenbrookes Hospital is 
the closest hospital to patients living in Cambridge city and 
South Cambridgeshire and being a tertiary referral centre, it 
would serve all patients in Cambridge in addition to receiving 
referrals from outside Cambridge. Very few diabetic patients 
would be referred elsewhere for treatment. Our results were 
cross-checked with the relevant Primary Care Trusts and both 
sets of data correlated very well. The Primary Care Trusts had 
no record of any patient living in the study population, who 
was registered visually impaired outside of Addenbrookes or 
Hinchingbrooke Hospitals or from the private sector in the 
study period. The possibility of a large number patients being 
registered visually impaired in the private sector is unlikely.
It is well known that there are limitations in using VI 
registration data to study rates of VI.15,16,17 VI registration 
data are hospital-based, not population-based.5 The patient 
must access the hospital eye service in order to be seen by 
a consultant ophthalmologist. Between 43% and 58% of 
eligible outpatients are said to remain unregistered even after 
consultation with an ophthalmologist,15,16 and up to 40% of 
registered patients are inappropriately registered.15 Patient 
attitudes to registration process (patients are entitled to 
refuse the offer), and medical attitudes to registration (there 
is no statutory requirement for it to be offered) also affect 
registration rates.5,18 There is often a delay between onset of 
certiﬁ  able visual loss and offer of registration.5 Studies have 
shown that certiﬁ  cation of VI is biased towards severe visual 
loss, permanent, nontreatable causes, and those that affect 
central rather than peripheral vision.15,17 Ethnic minorities are 
less likely to undergo registration.16,19 A prospective audit of 
Table 4 Demographics of Cambridgeshire (Census 2001)
Cambridge City, South
and Huntingdonshire
Cambridgeshire England and Wales
Total population 395,933 552,658 52,041,916
 Male 49.7% 49.5% 48.7%
 Female 50.3% 50.5% 51.3%
Ethnic group
 White 95.0% 95.9% 90.0%
 Mixed 1.2% 1.0% 1.5%
 Asian 1.7% 1.3% 4.5%
 Black 0.7% 0.6% 3.0%
Chinese/Other 1.4% 1.2% 1.0%
Age (years)
 0–15 19.3% 19.4% 18.7%
 16–74 74.2% 73.6% 74.0%
 75+ 6.5% 7.0% 7.3%
Note: Percentages given are proportions of the total population of the column.Clinical Ophthalmology 2009:3 79
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incident VI would be more useful. Despite these limitations, 
data on VI registration rates may be useful as estimates of 
incidence of VI and to establish a baseline for DR screening 
programmes.
Conclusions
From our study it would appear that registration of severe 
VI secondary to DR is uncommon and does not appear to be 
the main cause of VI registration in the working age group in 
this population of Cambridgeshire. The severe VI registration 
rate due to DR lies within the 1990–1991 national standard. 
The VI registration rate exceeds 1990–1991 national stan-
dard but lies within 1999–2000 national ﬁ  gures. These rates 
form a baseline for the region, to which future rates can be 
compared. We are unlikely to be able to achieve a lower rate 
of severe VI registration from DR. Improvement in VI due 
to DR may depend on improving other aspects of diabetic 
care, such as control of blood glucose and blood pressure, 
particularly before retinopathy occurs, and timely referral of 
patients with sight-threatening retinopathy.
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